Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
» TPI's 10-Y Financials

Financials (Next Earnings Date: 0)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

TPI Guru Trades in Q1 2015

Jim Simons 771,600 sh (+4.57%)
» More
Q2 2015

TPI Guru Trades in Q2 2015

Jim Simons 779,600 sh (+1.04%)
» More
Q3 2015

TPI Guru Trades in Q3 2015

Jim Simons 791,300 sh (+1.50%)
» More
Q4 2015

TPI Guru Trades in Q4 2015

Jim Simons 802,800 sh (+1.45%)
» More
» Details

Insider Trades

Latest Guru Trades with TPI

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history

Valuation & Return

vs
industry
vs
history

More Statistics

Revenue(Mil) $30
EPS $ -0.14
Beta2.51
Short Percentage of Float0.25%
52-Week Range $0.10 - 0.53
Shares Outstanding(Mil)29.43

Business Description

Industry: Drug Manufacturers » Drug Manufacturers - Specialty & Generic
Compare:ASX:QRX, BOM:531398, TSXV:BCC, XCNQ:EAT, BOM:524703 » details
Traded in other countries:60T.Germany,
Tianyin Pharmaceutical Co Inc previously called Viscorp, Inc., was originally formed as a limited liability company under the laws of the State of Delaware on August 20, 2002. The Company is engaged in the development, manufacturing, marketing and sales of patented biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines, and other pharmaceuticals in China. The Company currently manufactures a portfolio of 58 products, 24 of which are listed in the National Medical Reimbursement List and 10 are listed in the National Essential Drug List of China. It sells its products via regional distributors as well as directly to the hospitals, clinics, and pharmacies in China. Its geographical location at Sichuan province facilitates an access to high-grade raw ingredients for both raw materials for chemical medicine as well as Chinese medicines. The traditional Chinese medicine (TCM) industry in China is fragmented and intensely competitive. It faces competition from domestic TCM manufacturers, as well as domestic and foreign pharmaceuticals providers with similar therapeutic effects. China's pharmaceutical industry is regulated by the government. The primary regulatory authority is the CFDA, including its provincial and local branches, by which it is subject to regulation and oversight. China's healthcare laws stipulate the production and sale of pharmaceuticals in China, covering the manufacturing, distributing, packaging, pricing and advertising of pharmaceutical products. It is also subject to other Chinese laws and regulations that are applicable to business operators, manufacturers and distributors in general.
» More Articles for AMEX:TPI

Headlines

Articles On GuruFocus.com
8 Healthcare Dividend Stocks Close To 52-Week Low Sep 03 2011 

More From Other Websites
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Apr 07 2016
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Mar 02 2016
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Notice of Delisting or Failure to Satisfy a... Jan 11 2016
TPI Received Acceptance Letter From NYSE MKT Regarding its Plan of Compliance with Continued Listing... Jan 11 2016
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K/A, Other Events Dec 23 2015
TIANYIN PHARMACEUTICAL CO., INC. Financials Dec 08 2015
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Dec 02 2015
TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements Dec 02 2015
Tianyin Pharmaceutical Co., Inc. – Value Analysis (NYSE MKT:TPI) : November 3, 2015 Nov 03 2015
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Oct 19 2015
TPI Received Notice of Non-Compliance with NYSE MKT Continued Listing Requirements Oct 19 2015
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Other Events Oct 16 2015
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Other Events Sep 22 2015
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 10-Q/A, Quarterly Report Aug 20 2015
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Non-Reliance on Previous Financials, Audits or... Aug 11 2015
TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements Jul 30 2015
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a... Jul 17 2015
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jul 14 2015
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Submission of Matters to a Vote of Security... Jun 25 2015
TIANYIN PHARMACEUTICAL CO., INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws;... Jun 22 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK